Pablo Jimenez-Labaig

3PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 30, 2026
"SMAC"-down for the apoptosis-restoring drug, Xevinapant: What does its story reveal?

|Nov 28, 2025
Second-event endpoints (EFS2, PRFS2 and PFS2) after anti-PD-(L)1-based RCTs: a systematic review and meta-analysis.

Pablo Jimenez-Labaig, Oriol Mirallas, Ana Isabel Martin-Quesada

|May 03, 2024
A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis.

Pablo Jimenez-Labaig, Claudia Aymerich, Irene Braña

Pageof 1